In cancer patients, miRNAs are abundant as circulating molecules: actively secreted by tumor cells into exosomes, passively released in the extracellular space bound to the Argonaut 2 protein (Ago2), or as free molecules derived from apoptotic or necrotic tumor cells [6,7]. Here, AGO2 is linked to neoplasm.